Ivonescimab
UC-GIG-2411
Phase 2 small_molecule active
Quick answer
Ivonescimab for Metastatic Esophageal Adenocarcinoma is a Phase 2 program (small_molecule) at Summit Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Summit Therapeutics
- Indication
- Metastatic Esophageal Adenocarcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active